This study is a real-world study to observe the role of adjuvant radiotherapy in locally advanced recurrent high-risk thyroid cancer. The study included thyroid cancer that requires adjuvant radiotherapy to increase local control rate, excluding undifferentiated cancer. Local-regional recurrence free survival is the primary endpoint of the study.
Study Type
OBSERVATIONAL
Enrollment
80
The patients would receive external radiation therapy within 6 weeks after surgery, using intensity-modulated radiation therapy (IMRT) or volume modulated radiation therapy (VMAT) techniques. 6MV-X-ray irradiation. Conventional segmented irradiation is used, once a day, five times a week, with a segmented dose of 2Gy per dose.
Fudan University Shanghai Cancer Center
Shanghai, China
RECRUITINGLRRFS
Local-regional Recurrence Free Survival
Time frame: 5 years
DCR
Disease Control Rate
Time frame: 5 years
PFS
Progression Free Survival
Time frame: 5 years
OS
Overall Survival
Time frame: 5 years
AE
Adverse Events
Time frame: 5 years
QoL
Quality of Life
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.